SE9101433D0 - Recombinant dna sequence and its use - Google Patents
Recombinant dna sequence and its useInfo
- Publication number
- SE9101433D0 SE9101433D0 SE9101433A SE9101433A SE9101433D0 SE 9101433 D0 SE9101433 D0 SE 9101433D0 SE 9101433 A SE9101433 A SE 9101433A SE 9101433 A SE9101433 A SE 9101433A SE 9101433 D0 SE9101433 D0 SE 9101433D0
- Authority
- SE
- Sweden
- Prior art keywords
- gram positive
- recombinant dna
- protein
- cell wall
- dna sequence
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 2
- 238000004873 anchoring Methods 0.000 abstract 2
- 210000002421 cell wall Anatomy 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 108700011201 Streptococcus IgG Fc-binding Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/882—Staphylococcus
- Y10S435/883—Staphylococcus aureus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101433A SE9101433D0 (sv) | 1991-05-13 | 1991-05-13 | Recombinant dna sequence and its use |
AU17899/92A AU664841B2 (en) | 1991-05-13 | 1992-05-11 | Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
DE69233375T DE69233375T2 (de) | 1991-05-13 | 1992-05-11 | Für ein signalpeptid, ein selektiv wechselwirkendes polypeptid und eine membranankersequenz kodierende rekombinante dns |
EP92910363A EP0584167B1 (en) | 1991-05-13 | 1992-05-11 | Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
CA002103021A CA2103021C (en) | 1991-05-13 | 1992-05-11 | Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
JP51056892A JP3423712B2 (ja) | 1991-05-13 | 1992-05-11 | シグナルペプチド、選択的相互作用ポリペプチド及び膜固定配列をコードする組換えdna配列 |
AT92910363T ATE270335T1 (de) | 1991-05-13 | 1992-05-11 | Für ein signalpeptid, ein selektiv wechselwirkendes polypeptid und eine membranankersequenz kodierende rekombinante dns |
PCT/SE1992/000304 WO1992020805A1 (en) | 1991-05-13 | 1992-05-11 | Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
OA60434A OA09866A (en) | 1991-05-13 | 1993-11-11 | Recombinant DNA coding for signal peptide; selective interacting polypeptide and membrane anchoring sequence. |
US08/629,039 US5958736A (en) | 1991-05-13 | 1996-04-08 | Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101433A SE9101433D0 (sv) | 1991-05-13 | 1991-05-13 | Recombinant dna sequence and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9101433D0 true SE9101433D0 (sv) | 1991-05-13 |
Family
ID=20382707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9101433A SE9101433D0 (sv) | 1991-05-13 | 1991-05-13 | Recombinant dna sequence and its use |
Country Status (10)
Country | Link |
---|---|
US (1) | US5958736A (xx) |
EP (1) | EP0584167B1 (xx) |
JP (1) | JP3423712B2 (xx) |
AT (1) | ATE270335T1 (xx) |
AU (1) | AU664841B2 (xx) |
CA (1) | CA2103021C (xx) |
DE (1) | DE69233375T2 (xx) |
OA (1) | OA09866A (xx) |
SE (1) | SE9101433D0 (xx) |
WO (1) | WO1992020805A1 (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821088A (en) * | 1990-05-11 | 1998-10-13 | Siga Pharmaceuticals, Inc. | Use of gram-positive bacteria to express recombinant proteins |
US6737521B1 (en) * | 1990-05-11 | 2004-05-18 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
CA2131995A1 (en) * | 1992-03-13 | 1993-09-16 | Vincent A. Fischetti | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
EP0682710B1 (en) * | 1993-02-10 | 2003-10-29 | Unilever Plc | Isolation process using immobilized proteins with specific binding capacities |
US6740734B1 (en) * | 1994-01-14 | 2004-05-25 | Biovitrum Ab | Bacterial receptor structures |
FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
FR2726577B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament |
FR2726471B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins |
CN1160469C (zh) | 1994-12-09 | 2004-08-04 | 帝国大学改革有限公司 | 基因的鉴定 |
FR2766192B1 (fr) * | 1997-07-17 | 2001-07-13 | Pf Medicament | Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie |
FR2766091A1 (fr) * | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
WO2000014240A2 (en) | 1998-09-04 | 2000-03-16 | Creatogen Aktiengesellschaft | Attenuated salmonella sp12 mutants as antigen carriers |
GB9910812D0 (en) | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
EP1377306A1 (en) * | 2001-03-09 | 2004-01-07 | Dyax Corp. | Serum albumin binding moieties |
EP2075256A2 (en) | 2002-01-14 | 2009-07-01 | William Herman | Multispecific binding molecules |
EP1532173A4 (en) * | 2002-06-14 | 2006-03-08 | Dyax Corp | PROTEIN ANALYSIS |
US20040071705A1 (en) * | 2002-06-21 | 2004-04-15 | Dyax Corporation | Serum protein-associated target-specific ligands and identification method therefor |
WO2008127457A2 (en) * | 2006-12-06 | 2008-10-23 | Repligen Corporation | Nucleic acids encoding recombinant protein a |
US8017337B2 (en) * | 2007-04-19 | 2011-09-13 | Molecular Detection, Inc. | Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
WO2009158240A1 (en) | 2008-06-16 | 2009-12-30 | Emergent Product Development Uk Limited | Salmonella vectored vaccines against chlamydia and methods of use |
WO2016197064A1 (en) | 2015-06-04 | 2016-12-08 | Epstein Alan L | Lym-1 and lym-2 targeted car cell immunotherapy |
JP7196104B2 (ja) | 2017-06-05 | 2022-12-26 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | 増強された改変ウイルスカプシドタンパク質 |
AU2020311897A1 (en) | 2019-07-08 | 2022-02-03 | Research Institute At Nationwide Children's Hospital | Antibody compositions for disrupting biofilms |
AU2022358523A1 (en) | 2021-09-30 | 2024-03-14 | The Board Of Regents Of The Universityof Texas System | Slc13a5 gene therapy vectors and uses thereof |
WO2023096996A2 (en) | 2021-11-24 | 2023-06-01 | Research Institute At Nationwide Children's Hospital | Chimeric hsv expressing hil21 to boost anti-tumor immune activity |
WO2023102406A1 (en) | 2021-12-01 | 2023-06-08 | The Board Of Regents Of The Univesity Of Texas System | Vector genome design to express optimized cln7 transgene |
WO2023102518A1 (en) | 2021-12-03 | 2023-06-08 | The Board Of Regents Of The University Of Texas System | Gnao1 gene therapy vectors and uses thereof |
WO2023147476A1 (en) | 2022-01-28 | 2023-08-03 | The Board Of Regents Of The University Of Texas System | Transgene casette designed to express the human codon-optimized gene fmr1 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0109861A3 (en) * | 1982-11-23 | 1986-05-14 | Bio-Response Inc. | Method for isolating cells |
US5200327A (en) * | 1985-11-06 | 1993-04-06 | Cangene Corporation | Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
US4859609A (en) * | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
DE3852304T3 (de) * | 1987-03-02 | 1999-07-01 | Enzon Lab Inc | Organismus als Träger für "Single Chain Antibody Domain (SCAD)". |
DE3744595A1 (de) * | 1987-12-31 | 1989-07-13 | Andreas Dr Plueckthun | Verfahren zur gentechnischen herstellung von antikoerpern |
WO1989007140A1 (en) * | 1988-02-05 | 1989-08-10 | Commonwealth Scientific And Industrial Research Or | Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence |
-
1991
- 1991-05-13 SE SE9101433A patent/SE9101433D0/xx unknown
-
1992
- 1992-05-11 AU AU17899/92A patent/AU664841B2/en not_active Ceased
- 1992-05-11 WO PCT/SE1992/000304 patent/WO1992020805A1/en active IP Right Grant
- 1992-05-11 DE DE69233375T patent/DE69233375T2/de not_active Expired - Lifetime
- 1992-05-11 AT AT92910363T patent/ATE270335T1/de not_active IP Right Cessation
- 1992-05-11 EP EP92910363A patent/EP0584167B1/en not_active Expired - Lifetime
- 1992-05-11 JP JP51056892A patent/JP3423712B2/ja not_active Expired - Lifetime
- 1992-05-11 CA CA002103021A patent/CA2103021C/en not_active Expired - Lifetime
-
1993
- 1993-11-11 OA OA60434A patent/OA09866A/en unknown
-
1996
- 1996-04-08 US US08/629,039 patent/US5958736A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1992020805A1 (en) | 1992-11-26 |
CA2103021C (en) | 2000-07-04 |
EP0584167B1 (en) | 2004-06-30 |
US5958736A (en) | 1999-09-28 |
AU664841B2 (en) | 1995-12-07 |
EP0584167A1 (en) | 1994-03-02 |
ATE270335T1 (de) | 2004-07-15 |
JP3423712B2 (ja) | 2003-07-07 |
CA2103021A1 (en) | 1992-12-01 |
AU1789992A (en) | 1992-12-30 |
JPH07502640A (ja) | 1995-03-23 |
OA09866A (en) | 1994-08-15 |
DE69233375D1 (de) | 2004-08-05 |
DE69233375T2 (de) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9101433D0 (sv) | Recombinant dna sequence and its use | |
EP1092774A3 (en) | Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof | |
HK1013847A1 (en) | Gdf-1 and uog-1 proteins | |
DE69333802D1 (de) | Äusseres membranprotein von haemophilus | |
ZA91134B (en) | New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses | |
AU3664695A (en) | Infective protein delivery system | |
HUP0001650A2 (hu) | Javított expressziós vektorok | |
NO864759D0 (no) | Eutaryotiske fusjonsproteiner, fremstilling og anvendelse derav samt middel til gjennomfoering av fremgangsmaaten. | |
EP0539530A4 (en) | Purification directed cloning of peptides. | |
AU3192889A (en) | T cell activation markers | |
DK0531300T3 (da) | Variant-CD44-overfladeproteiner, DNA-sekvenser, som koder herfor, antistoffer mod disse proteiner samt deres anvendelse til diagnostik og terapi | |
EP0383837A4 (en) | Alveolar surfactant proteins | |
DK0614980T3 (da) | Trans-dominante TAT-varianter fra humant immundeficiens-virus | |
CA2083177A1 (en) | Alveolar surfactant proteins | |
ES8704207A1 (es) | Procedimiento para preparar una molecula de adn | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
AU7873798A (en) | N-terminally extended proteins expressed in yeast | |
AU5776799A (en) | Modified hcv peptide vaccines | |
DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
ES2012283A6 (es) | Procedimiento de obtencion de una proteina de endotoxina de efecto insecticida. | |
CA2163805A1 (en) | Novel activating factor of leukocytes | |
EP0345792A3 (en) | Htlv-i / hiv-1 fusion proteins | |
WO1999055862A3 (en) | Human proteins having transmembrane domains and dnas encoding these proteins | |
Tekamp-Olson | Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences | |
EP0953642A4 (en) | ANTIGENIC PROTEIN DRAWN FROM THE INFECTIOUS LARYNGO-TRACHEITIS VIRUS |